, Volume 32, Issue 1-2, pp 109-122
Date: 01 Nov 2012

Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

More than 15 years ago, the first generation of genetically engineered mouse (GEM) models of prostate cancer was introduced. These transgenic models utilized prostate-specific promoters to express SV40 oncogenes specifically in prostate epithelium. Since the description of these initial models, there have been a plethora of GEM models of prostate cancer representing various perturbations of oncogenes or tumor suppressors, either alone or in combination. This review describes these GEM models, focusing on their relevance for human prostate cancer and highlighting their strengths and limitations, as well as opportunities for the future.